Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Comment by MBAon Jan 22, 2018 1:07pm
423 Views
Post# 27409122

RE:Response is Muted

RE:Response is MutedResponse is as expected given the news release confirms the slow organic growth which we all expected. On the good news side, improving margins is good. If Crawford can maintain a 20% EBITDA on revenues, that would put new PHM now at $15 million (annualized). At 14 cents, the stock is only trading at a 3.5 x multiple. Lots of upward room for movement once the exciting part of the story (growth y acquisition) gets off the ground. Crawford touches on this but states he will provide a further update later on his acquisition plans. As for the move in VMD, I believe this may be linked to the greater market exposure provided by PSDFinancier (on Alpha and some of his posts) plus expectations Bruce Campbell will be high on VMD via BNN this Wednesday
Bullboard Posts